FDA Inspection 1051308 — James Kelley, M.D.
The FDA completed an inspection of James Kelley, M.D. on Apr 5, 2018 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 5, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Houston, TX (United States)
Additional Details
Clinical Investigator (CI)